Elite Pharmaceuticals Inc (ELTP)

[kayak_wench]

List of most recent Elite Bioequivalence PRs

I think there is a good chance of Elite having PR for the successful bioequivalence of Oxy given they can just leave out what it is other than a 'undisclosed generic product' as they have done in the past.

Feb 07, 2023 -> undisclosed generic drug product in a class of medications called antimetabolites . IQVIA of $42 million
Nov 02, 2022 -> drug product in a class of medications called dopamine agonists. IQVIA of $12 million
Oct 23, 2018 -> generic version of an antibiotic product. IQVIA of $94 million
Aug 14, 2018 -> immediate-release antibiotic generic product. IQVIA of $70 million
Jan 10, 2018 -> undisclosed extended-release generic product.
Jul 07, 2017 -> Pivotal Fed Bioequivalence Study For SequestOx™
May 30, 2017 -> undisclosed generic product IQVIA of $600 million